Molecular modelling of hepatitis B virus polymerase: Comparison of adefovir, entecavir and lamivudine resistance

被引：0
|
作者：
Bartholomeusz, A
Locarnini, S
Colledge, D
Ayres, A
Kuiper, M
Chalmers, D
机构：
[1] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[2] Victorian Partnership Adv Comp, Melbourne, Vic, Australia
[3] Vic Coll Pharm, Parkville, Vic, Australia
来源：
ANTIVIRAL RESEARCH | 2004年 / 62卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
49
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [31] THE EFFICACY OF ENTECAVIR IN CHRONIC HEPATITIS B PATIENTS WITH POOR RESPONSE TO ADEFOVIR THERAPY AFTER DEVELOPMENT OF LAMIVUDINE RESISTANCE
    Kim, Hyoung Su
    Park, Ji Won
    Shin, Woon Geon
    Kim, Kyung Ho
    Lee, Jin Heon
    Kim, Hak Yang
    Shin, Su Rin
    Kim, Young Mook
    Hahn, Tae Ho
    Jang, Myoung KuK
    Park, Sang Hoon
    Kim, Dong Joon
    Lee, Myung Seok
    Park, Choong Kee
    HEPATOLOGY, 2009, 50 (04) : 511A - 512A
  • [32] Measurement of resistance to Adefovir and Entecavir upon detection of Lamivudine resistance
    Ozeki, Itaru
    Nakajima, Tomoaki
    Hige, Shuhei
    Karino, Yoshiyasu
    Toyota, Joji
    HEPATOLOGY, 2012, 56 : 400A - 400A
  • [33] Pyrosequencing-based approach for rapid detection of Hepatitis B Virus infection resistant to lamivudine, adefovir and entecavir
    Meng, Chengyan
    Jin, Jialing
    Zhang, Wenhogn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A134 - A135
  • [34] Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
    Wang, Guiliang
    Liu, Yan
    Qiu, Ping
    Zhou, Shu-Feng
    Xu, Linfang
    Wen, Ping
    Wen, Jianbo
    Xiao, Xianzhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2839 - 2846
  • [35] Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir
    Kwak, M. S.
    Choi, J. W.
    Lee, J. S.
    Kim, K. A.
    Suh, J. H.
    Cho, Y. S.
    Won, S. Y.
    Park, B. K.
    Lee, C. K.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (10) : E432 - E438
  • [36] Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B
    Liu, Yan
    Wang, Chunmei
    Zhong, Yanwei
    Chen, Li
    Li, Xiaodong
    Ji, Dong
    Wang, Huifen
    Xin, Shaojie
    Zoulim, Fabien
    Xu, Dongping
    ANTIVIRAL THERAPY, 2010, 15 (08) : 1185 - 1190
  • [37] Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance
    Sea, Seung Young
    Kim, In Hee
    Sohn, Ji Youn
    Lee, Seok
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae-Ghon
    INTERVIROLOGY, 2014, 57 (01) : 8 - 16
  • [38] Rescue therapy for lamivudine-resistanct chronic hepatitis B: comparison between adefovir and entecavir rescue therapy
    Choi, Y.
    Kim, H. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A168 - A168
  • [39] Inhibition of hepatitis B virus polymerase by entecavir
    Langley, David R.
    Walsh, Ann W.
    Baldick, Carl J.
    Eggers, Betsy J.
    Rose, Ronald E.
    Levine, Steven M.
    Kapur, A. Jayne
    Colonno, Richard J.
    Tenney, Daniel J.
    JOURNAL OF VIROLOGY, 2007, 81 (08) : 3992 - 4001
  • [40] Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
    Park, Jung Gil
    Park, Soo Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (03) : 242 - 248
12345